Yunhong Zha
Overview
Explore the profile of Yunhong Zha including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
642
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wei J, Li M, Ye Z, Hu X, He X, Wang J, et al.
Signal Transduct Target Ther
. 2023 Dec;
8(1):451.
PMID: 38086800
Amyotrophic lateral sclerosis (ALS) is a devastating fatal neurodegenerative disease with no cure. Receptor-interacting protein kinase 1 (RIPK1) has been proposed to mediate pathogenesis of ALS. Primidone has been identified...
2.
Xiao X, Li M, Ye Z, He X, Wei J, Zha Y
Amyotroph Lateral Scler Frontotemporal Degener
. 2023 Nov;
25(1-2):1-15.
PMID: 37926865
Objective: Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease associated with upper and lower motor neuron degeneration and necrosis, characterized by progressive muscle weakness, atrophy, and paralysis. The mutation-associated...
3.
Quizartinib inhibits necroptosis by targeting receptor-interacting serine/threonine protein kinase 1
Li M, Wei J, Zhu G, Fu S, He X, Hu X, et al.
FASEB J
. 2023 Sep;
37(10):e23178.
PMID: 37698367
Systemic inflammatory response syndrome (SIRS), at least in part driven by necroptosis, is characterized by life-threatening multiple organ failure. Blocking the progression of SIRS and consequent multiple organ dysfunction is...
4.
He X, Li M, Ye Z, You X, Wang J, Xiao X, et al.
Drug Des Devel Ther
. 2023 May;
17:1387-1394.
PMID: 37188283
Purpose: Excessive necroptosis contributes to the pathogenesis of several inflammatory and neurodegenerative diseases. Here, using a high-throughput screening approach, we investigated the anti-necroptosis effects of piperlongumine, an alkaloid isolated from...
5.
Tran G, Ding J, Ye B, Liu M, Yu Y, Zha Y, et al.
Cancer Res
. 2023 Apr;
83(13):2248-2261.
PMID: 37057874
Significance: Caffeine treatment and FOXM1 inhibition can both enhance the antitumor effect of statins by blocking the molecular and metabolic processes that confer statin resistance, indicating potential combination therapeutic strategies...
6.
Yu L, Yang K, He X, Li M, Gao L, Zha Y
Cell Death Discov
. 2023 Feb;
9(1):57.
PMID: 36765040
Sepsis is a systemic inflammatory syndrome (SIRS) caused by acute microbial infection, and it has an extremely high mortality rate. Tumor necrosis factor-α (TNF-α)-induced necroptosis contributes to the pathophysiology of...
7.
Yu Y, Li M, Fu S, He X, Hu X, Zhu G, et al.
Int Immunol
. 2022 Dec;
35(5):221-230.
PMID: 36534968
Receptor-interacting protein kinase 1 (RIPK1) has emerged as a key regulator of cell death and inflammation, which are implicated in the pathogenesis of many inflammatory and degenerative diseases. RIPK1 is...
8.
Mou Y, Li M, Liu M, Wang J, Zhu G, Zha Y
Neurol Sci
. 2022 Jun;
43(9):5391-5396.
PMID: 35661277
Introduction: Optineurin (OPTN)-associated mutations have been implicated in the development of type 12 amyotrophic lateral sclerosis (ALS12). We reported a case of ALS with a new OPTN variant (p.D527fs) and...
9.
Yan M, Xiong M, Dai L, Zhang X, Zha Y, Deng X, et al.
NPJ Parkinsons Dis
. 2022 Jan;
8(1):1.
PMID: 35013321
The pathological hallmark of Parkinson's disease (PD) is the presence of Lewy bodies (LBs) with aggregated α-synuclein being the major component. The abnormal α-synuclein aggregates transfer between cells, recruit endogenous...
10.
Li M, Han Y, Wang S, Yu Y, Liu M, Xia Y, et al.
Neurol Sci
. 2021 Nov;
43(1):243-253.
PMID: 34731335
Introduction: Becker muscular dystrophy (BMD) is a genetic and progressive neuromuscular disease caused by mutations in the dystrophin gene with no available cure. A case report and comprehensive review of...